Healthequity, Inc. income statement HQY

In fiscal 2026, which ended Jan 31, 2026, Healthequity, Inc. reported revenue of $1.3 billion, up 9.5% from the year before. Net income was $215.2 million, a profit margin of 16.4%. Operating income came to $322.5 million, an operating margin of 24.6%. Diluted earnings per share were $2.46. Over the twelve months ended Jul 31, 2026, revenue was $1.4 billion and net income was $236.5 million. Across the 10 fiscal years shown, revenue grew from $178.4 million in fiscal 2017 to $1.3 billion in fiscal 2026, about 24.8% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2027
Jul 31, 2026
FY 2026
Jan 31, 2026
FY 2025
Jan 31, 2025
FY 2024
Jan 31, 2024
FY 2023
Jan 31, 2023
FY 2022
Jan 31, 2022
FY 2021
Jan 31, 2021
FY 2020
Jan 31, 2020
FY 2019
Jan 31, 2019
FY 2018
Jan 31, 2018
FY 2017
Jan 31, 2017
Revenue
1,362
+7.3%
1,313
+9.5%
1,200
+20.0%
1,000
+16.0%
862
+13.9%
757
+3.1%
734
+37.9%
532
+85.2%
287
+25.1%
230
+28.7%
178
+40.7%
Cost of revenue
392
-8.1%
400
-5.3%
423
+12.1%
377
+1.9%
370
+11.5%
332
+4.3%
318
+54.4%
206
+94.3%
106
—
—
Gross profit
970
+15.1%
913
+17.5%
777
+24.8%
623
+26.6%
492
+15.8%
425
+2.3%
415
+27.4%
326
+79.9%
181
+34.3%
135
+26.9%
106
+46.5%
Research and development
278
+10.7%
263
+9.6%
240
+9.5%
219
+13.2%
193
+22.9%
157
+26.1%
125
+60.9%
78
+121.3%
35
+28.0%
27
+22.4%
22
+32.9%
Selling, general and administrative
230
+10.0%
215
-3.5%
223
+21.9%
183
+10.0%
166
+15.5%
144
+7.1%
134
+28.7%
105
+67.1%
63
+29.6%
48
+25.4%
38
+40.3%
Operating income
351
+49.9%
322
+98.6%
162
+37.9%
118
+1199.5%
9
+137.4%
-24
-171.3%
34
-55.8%
77
-0.9%
78
+42.7%
54
+32.0%
41
+57.6%
Interest expense
53
-16.9%
57
-5.8%
61
—
—
—
—
—
—
—
—
Other non-operating income (expense)
10
-29.6%
12
-15.5%
14
+12.0%
13
+906.8%
1
+121.4%
-6
-218.5%
5
+155.1%
-9
-473.9%
-2
+19.1%
-2
-79.0%
-1
-85.4%
Pretax income
309
+66.7%
277
+139.1%
116
+54.6%
75
+297.0%
-38
+42.9%
-67
-1712.1%
4
-90.4%
43
-43.1%
76
+45.3%
52
+30.1%
40
+57.0%
Income tax
72
+83.6%
62
+221.9%
19
+0.0%
19
+261.7%
-12
+46.8%
-22
-378.3%
-5
-234.5%
3
+81.9%
2
-60.2%
5
-64.9%
14
+53.7%
Net income
236
+62.2%
215
+122.5%
97
+73.6%
56
+313.1%
-26
+41.0%
-44
-601.3%
9
-77.7%
40
-46.3%
74
+56.0%
47
+79.6%
26
+58.8%
Basic EPS
2.79
+66.0%
2.50
+125.2%
1.11
+70.8%
0.65
+309.7%
-0.31
+41.5%
-0.53
-541.7%
0.12
-79.7%
0.59
-50.8%
1.20
+51.9%
0.79
+75.6%
0.45
+55.2%
Diluted EPS
2.76
+67.6%
2.46
+125.7%
1.09
+70.3%
0.64
+306.5%
-0.31
+41.5%
-0.53
-541.7%
0.12
-79.3%
0.58
-50.4%
1.17
+51.9%
0.77
+75.0%
0.44
+57.1%
Weighted average shares, basic
85
-2.3%
86
-0.8%
87
+1.5%
86
+1.3%
84
+1.6%
83
+12.0%
74
+10.8%
67
+8.4%
62
+2.5%
60
+2.9%
59
+3.3%
Weighted average shares, diluted
86
-3.3%
87
-1.5%
89
+2.2%
87
+3.0%
84
+1.6%
83
+9.8%
76
+10.6%
68
+8.0%
63
+2.5%
62
+3.3%
60
+1.8%
Other measures
Depreciation and amortization
158
+0.3%
155
-4.8%
162
+6.1%
153
-5.0%
161
+17.5%
137
+18.4%
116
+109.4%
55
+204.4%
18
+14.0%
16
+21.0%
13
+53.3%
EBITDA
509
+30.0%
477
+46.9%
325
+19.9%
271
+59.0%
170
+50.7%
113
-24.7%
150
+13.3%
132
+38.1%
96
+36.2%
70
+29.4%
54
+56.6%
Interest coverage
6.69x
5.64x
2.68x
—
—
—
—
—
—
—
—
Margins
Gross margin
71.25%
69.52%
64.78%
62.29%
57.09%
56.14%
56.62%
61.26%
63.08%
58.78%
59.63%
Operating margin
25.80%
24.55%
13.53%
11.77%
1.05%
-3.20%
4.64%
14.48%
27.04%
23.71%
23.10%
Pretax margin
22.66%
21.12%
9.67%
7.51%
-4.42%
-8.82%
0.56%
8.11%
26.40%
22.74%
22.49%
Profit margin
17.36%
16.38%
8.06%
5.57%
-3.03%
-5.85%
1.20%
7.46%
25.73%
20.63%
14.79%
EBITDA margin
37.37%
36.33%
27.07%
27.09%
19.76%
14.93%
20.44%
24.88%
33.37%
30.66%
30.50%
Effective tax rate
23.39%
22.43%
16.66%
25.76%
—
—
-113.38%
8.09%
2.53%
9.25%
34.26%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Services-Business Services, NEC (SIC 7389)
Listed as
HQY (Nasdaq)
Fiscal year ends
January 31
Incorporated in
DE
Headquarters
Draper, UT
SEC filer status
Large accelerated filer
SEC CIK
1428336
Former names
HEALTHEQUITY INC (until Jun 6, 2019)

Other Services-Business Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.